Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18
Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,395 | Dovepress* | 3,246+ | 63 | 3,309 | |
PubMed Central* | 149 | 137 | 286 | ||
Totals | 3,395 | 200 | 3,595 | ||
*Since 2 November 2022 |
View citations on PubMed Central and Google Scholar